Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury

Ciro Indolfi, Angelo Cioppa, Eugenio Stabile, Emilio Di Lorenzo, Giovanni Esposito, Alfonso Pisani, Antonio Leccia, Luigi Cavuto, Angela Maria Stingone, Alaide Chieffo, Claudia Capozzolo, Massimo Chiariello

Research output: Contribution to journalArticle

Abstract

OBJECTIVES: We sought to evaluate the effects of hydroxymethylglutaryl coenzyme A (HMG-CoA) reductase inhibitors on vascular smooth muscle cell (VSMC) proliferation in vitro and neointimal formation in vivo after vascular injury. BACKGROUND: Neointimal hyperplasia after vascular injury is responsible for restenosis after arterial stenting, whereas arterial remodeling and neointimal formation are the causes of restenosis after percutaneous transluminal coronary angioplasty. METHODS: We assessed the effect of simvastatin on in vitro VSMC proliferation. To study the effects of simvastatin in vivo, balloon injury and stent deployment were performed in the common carotid artery of rats. Neointimal area was measured two weeks later in the balloon injury model and three weeks after stent deployment. RESULTS: Simvastatin markedly inhibits VSMC proliferation in vitro. In vivo, simvastatin reduced, in a dose-dependent manner, the neointimal area and the neointima-media ratio after balloon injury from 0.266 ± 0.015 mm2 to 0.080 ± 0.026 mm2 and from 1.271 ± 0.074 to 0.436 ± 0.158 (p <0.001 vs. control rats) at the highest dose. Simvastatin also significantly reduced the neointimal formation and the neointima-media ratio after stenting from 0.508 ± 0.035 mm2 to 0.362 ± 0.047 mm2 (p <0.05 vs. control rats) and from 2.000 ± 0.136 to 1.374 ± 0.180 (p <0.05 vs. control rats). The vessel thrombosis rate after stent deployment was 30% in the control group and 11.1% in the treated group (p = NS). Moreover, the systemic administration of simvastatin did not affect hepatic and renal functions, blood pressure or heart rate. CONCLUSIONS: Simvastatin potently inhibits VSMC proliferation in vitro and reduces neointimal formation in a rat model of vascular injury.

Original languageEnglish
Pages (from-to)214-221
Number of pages8
JournalJournal of the American College of Cardiology
Volume35
Issue number1
DOIs
Publication statusPublished - Jan 2000

ASJC Scopus subject areas

  • Nursing(all)

Fingerprint Dive into the research topics of 'Effects of hydroxymethylglutaryl coenzyme A reductase inhibitor simvastatin on smooth muscle cell proliferation in vitro and neointimal formation in vivo after vascular injury'. Together they form a unique fingerprint.

  • Cite this